SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting
December 11, 2025
 · 
6 min read
Press Releases
Hemostemix Grants Stock Options
December 11, 2025
 · 
7 min read
Press Releases
Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)
December 11, 2025
 · 
9 min read
Press Releases
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
December 11, 2025
 · 
13 min read
Press Releases
Defence Therapeutics Announces AGM Results and Provides Corporate Updates
December 10, 2025
 · 
4 min read
Press Releases
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
December 10, 2025
 · 
6 min read
Press Releases
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000
December 10, 2025
 · 
8 min read
Press Releases
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
December 10, 2025
 · 
8 min read
Press Releases
MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
December 10, 2025
 · 
6 min read
Press Releases
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
December 9, 2025
 · 
6 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us